The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Akari Therapeutics Plc | COM | 00972G108 | 2,217 | 158,352 | SH | SOLE | 158,352 | 0 | 0 | ||
| Alcobra Ltd | COM | M2239P109 | 1,836 | 484,500 | SH | SOLE | 484,500 | 0 | 0 | ||
| Anacor Pharmaceuticals Inc | COM | 032420101 | 7,523 | 140,756 | SH | SOLE | 140,756 | 0 | 0 | ||
| ARCA biopharma Inc | COM | 00211Y100 | 1,605 | 462,399 | SH | SOLE | 462,399 | 0 | 0 | ||
| Ascendis Pharma A/S | COM | 04351P101 | 1,670 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| Avalanche Biotechnologies Inc | COM | 05337G107 | 5,701 | 1,102,735 | SH | SOLE | 1,102,735 | 0 | 0 | ||
| Axovant Sciences Ltd | COM | G0750W104 | 2,114 | 184,110 | SH | SOLE | 184,110 | 0 | 0 | ||
| BioCryst Pharmaceuticals Inc | COM | 09058V103 | 1,593 | 562,943 | SH | SOLE | 562,943 | 0 | 0 | ||
| BeiGene Ltd | COM | 07725L102 | 1,495 | 51,000 | SH | SOLE | 51,000 | 0 | 0 | ||
| Coherus Biosciences Inc | COM | 19249H103 | 12,972 | 611,010 | SH | SOLE | 611,010 | 0 | 0 | ||
| Cynapsus Therapeutics Inc | COM | 23257Y701 | 1,317 | 108,575 | SH | SOLE | 108,575 | 0 | 0 | ||
| CytomX Therapeutics Inc | COM | 23284F105 | 828 | 64,200 | SH | SOLE | 64,200 | 0 | 0 | ||
| DBV Technologies | COM | F2927N109 | 29,018 | 456,893 | SH | SOLE | 456,893 | 0 | 0 | ||
| Edge Therapeutics Inc | COM | 279870109 | 1,235 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| Flamel Technologies S.A. | COM | 338488109 | 5,520 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| Global Blood Therapeutics | COM | 37890U108 | 1,158 | 72,990 | SH | SOLE | 72,990 | 0 | 0 | ||
| Heron Therapeutics Inc | COM | 427746102 | 20,808 | 1,095,734 | SH | SOLE | 1,095,734 | 0 | 0 | ||
| Lipocine Inc | COM | 53630X104 | 8,627 | 849,921 | SH | SOLE | 849,921 | 0 | 0 | ||
| Ocera Therapeutics | COM | 67552A108 | 2,342 | 796,550 | SH | SOLE | 796,550 | 0 | 0 | ||
| ProNAI Therapeutics Inc | COM | 74346L101 | 378 | 56,056 | SH | SOLE | 56,056 | 0 | 0 | ||
| REGENXBIO Inc | COM | 75901B107 | 567 | 52,500 | SH | SOLE | 52,500 | 0 | 0 | ||
| Stemline Therapeutics Inc | COM | 85858C107 | 631 | 135,420 | SH | SOLE | 135,420 | 0 | 0 | ||
| Zafgen Inc | COM | 98885E103 | 4,022 | 602,114 | SH | SOLE | 602,114 | 0 | 0 | ||